CLINICAL_TRIALS
trial_result
· 2024-08-13
Clinical Trial Update: Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass [Phase 4]
Summary
Phase 4 clinical trial update evaluating optimal protamine dosing for reversing heparin after cardiopulmonary bypass; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Miami | Conditions: Coagulation; Intravascular | Phase 4 | Status: COMPLETED | Results posted: 2024-08-13